Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
India Globalization Capital | 2.210% | -2.158% | -6.207% | -13.924% | 3.817% | -78.378% | -71.658% |
Celsion Corp. | -1.100% | -3.704% | -16.514% | -4.712% | 52.941% | -92.646% | -95.810% |
Protara Therapeutics Inc. | 0.620% | -6.936% | -14.362% | 5.921% | -4.734% | -73.167% | - |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat